Dow Up 0.12% Nasdaq Up 1.35%

Orexigen Therapeutics, Inc. (OREX)

-NasdaqGS
4.06 Down 0.02(0.49%) Oct 20, 4:00PM EDT
|After Hours : 4.10 Up 0.04 (0.99%) Oct 20, 7:36PM EDT
Prev Close:4.08
Open:4.08
Bid:N/A
Ask:4.14 x 8000
1y Target Est:11.00
Beta:3.03
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:4.02 - 4.23
52wk Range:3.11 - 7.82
Volume:2,746,560
Avg Vol (3m):3,995,520
Market Cap:497.49M
P/E (ttm):N/A
EPS (ttm):-0.84
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for OREX

Comparison

Symbol% ChgMkt Cap
OREXDown 0.49%497.49M
ABTUp 1.47%62.34B
GSKDown 0.14%104.75B
RHHBYUp 1.26%243.60B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):145.84
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.33
Quarterly EPS Est (Sep-14) :-0.03
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-1.00

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback